Catalent Expands OneBio® Suite for Integrated Development, Manufacturing and Supply Across Biologic Modalities

FHS
June 16, 2023
12:31 pm

Catalen today announced that it has expanded its integrated development, manufacturing and supply solution, OneBio® Suite, across a range of biologic modalities, including antibody and recombinant proteins, cell and gene therapies, and mRNA.

Innovations in biomarker detection and personalized medicine for prostate cancer

In a recent comprehensive review published in Cyborg Bionic Systems, researchers led by Keyi Li from the General Hospital of Northern Theater Command in Shenyang,

August 23, 2024

Maternal gut bacteria linked to changes in fetal brain metabolism

The impact of Bifidobacterium breve’s presence in the maternal gut during pregnancy on fetal brain metabolism.

August 23, 2024

Tick season is here: How to avoid ticks

It’s tick season now and researchers from the University of Agder in Norway shed light on the myths and facts about these parasites.

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.